121 related articles for article (PubMed ID: 6106335)
1. [State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
Krupenina LB; Vinogradov MV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):737-45. PubMed ID: 6106335
[TBL] [Abstract][Full Text] [Related]
2. State of adrenergic and cholinergic systems in schizophrenia patients during psychopharmacotherapy.
Krupenina LB; Vinogradov MV
Neurosci Behav Physiol; 1985; 15(1):1-8. PubMed ID: 3923387
[No Abstract] [Full Text] [Related]
3. [Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
Misionzhnik EIu; Vertogradova OP; Krasnov VN; Salenko BB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(4):543-51. PubMed ID: 6168150
[TBL] [Abstract][Full Text] [Related]
4. [Various features of dopamine metabolism in schizophrenia].
Anokhina IP; Kogan BM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(9):1343-7. PubMed ID: 6798791
[TBL] [Abstract][Full Text] [Related]
5. Studies of catecholamine metabolism in two hereditary forms of dystonia.
Wotten GF; Eldridge R; Gordon EK; Axelrod J
Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
[No Abstract] [Full Text] [Related]
6. [Several biochemical mechanisms of the pathogenesis of Huntington chorea].
Barkhatova VP; Larskiĭ EG; Markova ED; Ivanova-Smolenskaia IA; Insarova NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(7):1038-45. PubMed ID: 6137919
[TBL] [Abstract][Full Text] [Related]
7. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system].
Käser H; Türler K; Burri PH
Schweiz Med Wochenschr; 1971 Apr; 101(13):484-7. PubMed ID: 5558918
[No Abstract] [Full Text] [Related]
8. [Features of the functioning of the catecholamine and adrenocortical systems of patients with depression and different degrees of emotional tension].
Anokhina ID; Bol'shakova TD; Bremer GP; Buniatian AF; Ignatenko LL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1703-8. PubMed ID: 3101334
[TBL] [Abstract][Full Text] [Related]
9. [Catecholamine metabolism in various compensatory manifestations of epilepsy patients].
Golodets RG; Lando LI; Afanas'ev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):324-8. PubMed ID: 442901
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis and treatment of torsion dystonia].
Barkhatova VP; Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
[TBL] [Abstract][Full Text] [Related]
11. [Excretion of catecholamines and tryptophan derivatives in schizophrenia].
Mileikovskii IuA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):710-4. PubMed ID: 132832
[TBL] [Abstract][Full Text] [Related]
12. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
[TBL] [Abstract][Full Text] [Related]
13. [Role of catecholamines in the biochemical mechanisms of the pathogenesis of hepatocerebral dystrophy].
Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):78-84. PubMed ID: 7124230
[TBL] [Abstract][Full Text] [Related]
14. [Effect of levodopa on the arterial pressure and the metabolism of catecholamines in essential hypertension].
Zaldívar HM; Monroy JR; Sánchez Torres G; Chávez Lara B; Serrano PA
Arch Inst Cardiol Mex; 1977; 47(5):591-603. PubMed ID: 603291
[No Abstract] [Full Text] [Related]
15. [Catecholamine metabolism in manic-depressive psychosis].
Usherenko LS
Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
[No Abstract] [Full Text] [Related]
16. [Age patterns in the dynamics of unfavorably developing forms of schizophrenia in the light of late follow-ups in old age].
Druzhinina TA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(1):79-85. PubMed ID: 32710
[TBL] [Abstract][Full Text] [Related]
17. [Several indices of the methylation process in schizophrenic patients].
Mys'ko GN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(7):1058-62. PubMed ID: 19907
[TBL] [Abstract][Full Text] [Related]
18. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
Vasil'ev VN
Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
[TBL] [Abstract][Full Text] [Related]
19. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
Alonso R; Gibson CJ; Wurtman RJ; Agharanya JC; Prieto L
Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
[TBL] [Abstract][Full Text] [Related]
20. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
